Substance use disorder (SUD) is the persistent use of drugs (including alcohol) despite substantial harm and adverse consequences.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Substance Use Disorders (SUDs) Treatment industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence
Market Segment by Product Application
Hospital & Clinics
Residential (non-hospital)
Finally, the report provides detailed profile and data information analysis of leading company.
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Substance Use Disorders (SUDs) Treatment consumption (value) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
2.To understand the structure of Substance Use Disorders (SUDs) Treatment market by identifying its various subsegments.
3.Focuses on the key global Substance Use Disorders (SUDs) Treatment manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Substance Use Disorders (SUDs) Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Substance Use Disorders (SUDs) Treatment submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Substance Use Disorders (SUDs) Treatment Market Research Report 2021, Forecast to 2026
1 Market Study Overview
1.1 Study Objectives
1.2 Substance Use Disorders (SUDs) Treatment Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Substance Use Disorders (SUDs) Treatment Segment by Type
2.1.1 Opioid Addiction
2.1.2 Tobacco/Nicotine Addiction
2.1.3 Alcohol Dependence
2.2 Market Analysis by Application
2.2.1 Hospital & Clinics
2.2.2 Residential (non-hospital)
2.3 Global Substance Use Disorders (SUDs) Treatment Market Comparison by Regions (2016-2026)
2.3.1 Global Substance Use Disorders (SUDs) Treatment Market Size (2016-2026)
2.3.2 North America Substance Use Disorders (SUDs) Treatment Status and Prospect (2016-2026)
2.3.3 Europe Substance Use Disorders (SUDs) Treatment Status and Prospect (2016-2026)
2.3.4 China Substance Use Disorders (SUDs) Treatment Status and Prospect (2016-2026)
2.3.5 Japan Substance Use Disorders (SUDs) Treatment Status and Prospect (2016-2026)
2.3.6 Southeast Asia Substance Use Disorders (SUDs) Treatment Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Substance Use Disorders (SUDs) Treatment Industry Impact
2.5.1 Substance Use Disorders (SUDs) Treatment Business Impact Assessment - Covid-19
2.5.2 Market Trends and Substance Use Disorders (SUDs) Treatment Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Substance Use Disorders (SUDs) Treatment Sales and Market Share by Manufacturer (2016-2021)
3.2 Global Substance Use Disorders (SUDs) Treatment Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global Substance Use Disorders (SUDs) Treatment Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Substance Use Disorders (SUDs) Treatment Manufacturer Market Share
3.5 Top 10 Substance Use Disorders (SUDs) Treatment Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Substance Use Disorders (SUDs) Treatment Market
3.7 Key Manufacturers Substance Use Disorders (SUDs) Treatment Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Substance Use Disorders (SUDs) Treatment Industry Key Manufacturers
4.1 Indivior
4.1.1 Compan Detail
4.1.2 Indivior Substance Use Disorders (SUDs) Treatment Product Introduction, Application and Specification
4.1.3 Indivior 137 Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 Indivior News
4.2 Pfizer
4.2.1 Compan Detail
4.2.2 Pfizer Substance Use Disorders (SUDs) Treatment Product Introduction, Application and Specification
4.2.3 Pfizer Substance Use Disorders (SUDs) Treatment Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 Indivior News
4.3 Alkermes
4.3.1 Compan Detail
4.3.2 Alkermes Substance Use Disorders (SUDs) Treatment Product Introduction, Application and Specification
4.3.3 Alkermes Substance Use Disorders (SUDs) Treatment Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 Alkermes News
4.4 Novartis
4.4.1 Compan Detail
4.4.2 Novartis Substance Use Disorders (SUDs) Treatment Product Introduction, Application and Specification
4.4.3 Novartis Substance Use Disorders (SUDs) Treatment Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 Novartis News
4.5 Mylan
4.5.1 Compan Detail
4.5.2 Novartis Substance Use Disorders (SUDs) Treatment Product Introduction, Application and Specification
4.5.3 Mylan Substance Use Disorders (SUDs) Treatment Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.5.4 Main Business Overview
4.5.5 Mylan News
4.6 Cipla
4.6.1 Compan Detail
4.6.2 Cipla Substance Use Disorders (SUDs) Treatment Product Introduction, Application and Specification
4.6.3 Cipla Substance Use Disorders (SUDs) Treatment Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.6.4 Main Business Overview
4.6.5 Cipla News
4.7 Glenmark
4.7.1 Compan Detail
4.7.2 Glenmark Substance Use Disorders (SUDs) Treatment Product Introduction, Application and Specification
4.7.3 Glenmark Substance Use Disorders (SUDs) Treatment Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Dr. Reddy's Laboratories
4.8.1 Compan Detail
4.8.2 Dr. Reddy's Laboratories Substance Use Disorders (SUDs) Treatment Product Introduction, Application and Specification
4.8.3 Dr. Reddy's Laboratories Substance Use Disorders (SUDs) Treatment Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.8.4 Main Business Overview
4.8.5 Dr. Reddy's Laboratories News
4.9 Teva Pharmaceutical
4.9.1 Compan Detail
4.9.2 Teva Pharmaceutical Substance Use Disorders (SUDs) Treatment Product Introduction, Application and Specification
4.9.3 Teva Pharmaceutical Substance Use Disorders (SUDs) Treatment Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.9.4 Main Business Overview
4.9.5 Teva Pharmaceutical News
5 Global Substance Use Disorders (SUDs) Treatment Market Segment by Big Type
5.1 Global Substance Use Disorders (SUDs) Treatment Revenue, Sales and Market Share by Big Type (2016-2021)
5.1.1 Global Substance Use Disorders (SUDs) Treatment Sales and Market Share by Big Type (2016-2021)
5.1.2 Global Substance Use Disorders (SUDs) Treatment Revenue and Market Share by Big Type (2016-2021)
5.2 Opioid Addiction Sales Growth Rate and Price
5.2.1 Global Opioid Addiction Sales Growth Rate (2016-2021)
5.2.2 Global Opioid Addiction Price (2016-2021)
5.3 Tobacco/Nicotine Addiction Sales Growth Rate and Price
5.3.1 Global Tobacco/Nicotine Addiction Sales Growth Rate (2016-2021)
5.3.2 Global Tobacco/Nicotine Addiction Price (2016-2021)
5.4 Alcohol Dependence Sales Growth Rate and Price
5.4.1 Global Alcohol Dependence Sales Growth Rate (2016-2021)
5.4.2 Global Alcohol Dependence Price (2016-2021)
6 Global Substance Use Disorders (SUDs) Treatment Market Segment by Big Application
6.1 Global Substance Use Disorders (SUDs) Treatment Sales Market Share by Big Application (2016-2021)
6.2 Hospital & Clinics Sales Growth Rate (2016-2021)
6.3 Residential (non-hospital) Sales Growth Rate (2016-2021)
7 Global Substance Use Disorders (SUDs) Treatment Forecast
7.1 Global Substance Use Disorders (SUDs) Treatment Revenue, Sales and Growth Rate (2021-2026)
7.2 Substance Use Disorders (SUDs) Treatment Market Forecast by Regions (2021-2026)
7.2.1 North America Substance Use Disorders (SUDs) Treatment Market Forecast (2021-2026)
7.2.2 Europe Substance Use Disorders (SUDs) Treatment Market Forecast (2021-2026)
7.2.3 China Substance Use Disorders (SUDs) Treatment Market Forecast (2021-2026)
7.2.4 Japan Substance Use Disorders (SUDs) Treatment Market Forecast (2021-2026)
7.2.5 Southeast Asia Substance Use Disorders (SUDs) Treatment Market Forecast (2021-2026)
7.2.6 Other Regions Substance Use Disorders (SUDs) Treatment Market Forecast (2021-2026)
7.3 Substance Use Disorders (SUDs) Treatment Market Forecast by Type (2021-2026)
7.3.1 Global Substance Use Disorders (SUDs) Treatment Sales Forecast by Type (2021-2026)
7.3.2 Global Substance Use Disorders (SUDs) Treatment Market Share Forecast by Type (2021-2026)
7.4 Substance Use Disorders (SUDs) Treatment Market Forecast by Application (2021-2026)
7.4.1 Global Substance Use Disorders (SUDs) Treatment Sales Forecast by Application (2021-2026)
7.4.2 Global Substance Use Disorders (SUDs) Treatment Market Share Forecast by Application (2021-2026)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Substance Use Disorders (SUDs) Treatment Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Substance Use Disorders (SUDs) Treatment Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Substance Use Disorders (SUDs) Treatment
Figure Market Concentration Ratio and Market Maturity Analysis of Substance Use Disorders (SUDs) Treatment
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Substance Use Disorders (SUDs) Treatment Market Size by Big Type
Figure Global Market Share of Substance Use Disorders (SUDs) Treatment by Big Type in 2020
Figure Opioid Addiction Picture (2016-2021)
Figure Tobacco/Nicotine Addiction Picture (2016-2021)
Global Substance Use Disorders (SUDs) Treatment Market Size by Big Application
Table Global Substance Use Disorders (SUDs) Treatment Market Size by Application
Figure Global Substance Use Disorders (SUDs) Treatment Market Share by Big Application in 2020
Figure Hospital & Clinics Picture
Figure Residential (non-hospital) Picture
Table Global Substance Use Disorders (SUDs) Treatment Comparison by Regions (M USD) (2016-2026)
Figure Global Substance Use Disorders (SUDs) Treatment Market Size (Million US$) (2016-2026)
Figure North America Substance Use Disorders (SUDs) Treatment Revenue (Million US$) Growth Rate (2016-2026)
Figure Europe Substance Use Disorders (SUDs) Treatment Revenue (Million US$) Growth Rate (2016-2026)
Figure China Substance Use Disorders (SUDs) Treatment Revenue (Million US$) Growth Rate (2016-2026)
Figure Japan Substance Use Disorders (SUDs) Treatment Revenue (Million US$) Growth Rate (2016-2026)
Figure Southeast Asia Substance Use Disorders (SUDs) Treatment Revenue (Million US$) Growth Rate (2016-2026)
Table Business Impact Assessment - Covid-19
Table Market Trends and Substance Use Disorders (SUDs) Treatment Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Substance Use Disorders (SUDs) Treatment Sales by Manufacturer (2016-2021)
Figure Global Substance Use Disorders (SUDs) Treatment Sales Market Share by Manufacturer in 2020
Table Global Substance Use Disorders (SUDs) Treatment Revenue by Manufacturer (2016-2021)
Figure Global Substance Use Disorders (SUDs) Treatment Revenue Market Share by Manufacturer in 2020
Table Global Substance Use Disorders (SUDs) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Substance Use Disorders (SUDs) Treatment Manufacturer (Revenue) Market Share in 2020
Figure Top 10 Substance Use Disorders (SUDs) Treatment Manufacturer (Revenue) Market Share in 2020
Table Date of Key Manufacturers Enter into Substance Use Disorders (SUDs) Treatment Market
Table Key Manufacturers Substance Use Disorders (SUDs) Treatment Product Type
Table Mergers & Acquisitions Planning
Table Indivior Company Profile
Table Substance Use Disorders (SUDs) Treatment Product Introduction, Application and Specification of Indivior
Table Substance Use Disorders (SUDs) Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2016-2021
Table Company One Main Business
Table Company One Recent Development
Table Pfizer Company Profile
Table Substance Use Disorders (SUDs) Treatment Product Introduction, Application and Specification of Pfizer
Table Substance Use Disorders (SUDs) Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Pfizer Recent Development
Table Alkermes Company Profile
Table Substance Use Disorders (SUDs) Treatment Product Introduction, Application and Specification of Alkermes
Table Substance Use Disorders (SUDs) Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Alkermes Main Business
Table Alkermes Recent Development
Table Novartis Company Profile
Table Substance Use Disorders (SUDs) Treatment Product Introduction, Application and Specification of Novartis
Table Substance Use Disorders (SUDs) Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Novartis Main Business
Table Novartis Recent Development
Table Novartis Main Business
Table Novartis Recent Development
Table Mylan Company Profile
Table Substance Use Disorders (SUDs) Treatment Product Introduction, Application and Specification of Mylan
Table Substance Use Disorders (SUDs) Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Mylan Main Business
Table Mylan Recent Development
Table Cipla Company Profile
Table Substance Use Disorders (SUDs) Treatment Product Introduction, Application and Specification of Cipla
Table Substance Use Disorders (SUDs) Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Cipla Main Business
Table Cipla Recent Development
Table Glenmark Company Profile
Table Substance Use Disorders (SUDs) Treatment Product Introduction, Application and Specification of Glenmark
Table Substance Use Disorders (SUDs) Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Glenmark Main Business
Table Glenmark Recent Development
Table Dr. Reddy's Laboratories Company Profile
Table Substance Use Disorders (SUDs) Treatment Product Introduction, Application and Specification of Dr. Reddy's Laboratories
Table Substance Use Disorders (SUDs) Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Dr. Reddy's Laboratories Main Business
Table Dr. Reddy's Laboratories Recent Development
Table Teva Pharmaceutical Company Profile
Table Substance Use Disorders (SUDs) Treatment Product Introduction, Application and Specification of Teva Pharmaceutical
Table Substance Use Disorders (SUDs) Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Teva Pharmaceutical Main Business
Table Teva Pharmaceutical Recent Development
Figure Global Substance Use Disorders (SUDs) Treatment Sales and Growth Rate (2016-2021)
Figure Global Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2016-2021)
Table Global Substance Use Disorders (SUDs) Treatment Sales by Regions (2016-2021)
Figure Global Substance Use Disorders (SUDs) Treatment Sales Market Share by Regions in 2020
Table Global Substance Use Disorders (SUDs) Treatment Revenue by Regions (2016-2021)
Figure Global Substance Use Disorders (SUDs) Treatment Revenue Market Share by Regions in 2020
Figure North America Substance Use Disorders (SUDs) Treatment Sales and Growth Rate (2016-2021)
Figure Europe Substance Use Disorders (SUDs) Treatment Sales and Growth Rate (2016-2021)
Figure China Substance Use Disorders (SUDs) Treatment Sales and Growth Rate (2016-2021)
Figure Japan Substance Use Disorders (SUDs) Treatment Sales and Growth Rate (2016-2021)
Figure Southeast Asia Substance Use Disorders (SUDs) Treatment Sales and Growth Rate (2016-2021)
Figure Other Regions Substance Use Disorders (SUDs) Treatment Sales and Growth Rate (2016-2021)
Table Global Substance Use Disorders (SUDs) Treatment Sales by Big Type (2016-2021)
Table Global Substance Use Disorders (SUDs) Treatment Sales Market Share by Big Type (2016-2021)
Figure Global Substance Use Disorders (SUDs) Treatment Sales Market Share by Big Type in 2019
Table Global Substance Use Disorders (SUDs) Treatment Revenue by Big Type (2016-2021)
Table Global Substance Use Disorders (SUDs) Treatment Revenue Market Share by Big Type (2016-2021)
Table Global Substance Use Disorders (SUDs) Treatment Revenue Market Share by Big Type in 2019
Figure Global Opioid Addiction Sales Growth Rate (2016-2021)
Figure Global Opioid Addiction Price (2016-2021)
Figure Global Tobacco/Nicotine Addiction Sales Growth Rate (2016-2021)
Figure Global Tobacco/Nicotine Addiction Price (2016-2021)
Figure Global Alcohol Dependence Sales Growth Rate (2016-2021)
Table Global Substance Use Disorders (SUDs) Treatment Sales by Big Application (2016-2021)
Table Global Substance Use Disorders (SUDs) Treatment Sales Market Share by Big Application (2016-2021)
Figure Global Substance Use Disorders (SUDs) Treatment Sales Market Share by Big Application in 2019
Figure Global Hospital & Clinics Sales Growth Rate (2016-2021)
Figure Global Residential (non-hospital) Sales Growth Rate (2016-2021)
Figure Global Substance Use Disorders (SUDs) Treatment Sales and Growth Rate (2021-2026)
Figure Global Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2021-2026)
Table Global Substance Use Disorders (SUDs) Treatment Sales Forecast by Regions (2021-2026)
Table Global Substance Use Disorders (SUDs) Treatment Market Share Forecast by Regions (2021-2026)
Figure North America Sales Substance Use Disorders (SUDs) Treatment Market Forecast (2021-2026)
Figure Europe Sales Substance Use Disorders (SUDs) Treatment Market Forecast (2021-2026)
Figure China Sales Substance Use Disorders (SUDs) Treatment Market Forecast (2021-2026)
Figure Japan Sales Substance Use Disorders (SUDs) Treatment Market Forecast (2021-2026)
Figure Southeast Asia Sales Substance Use Disorders (SUDs) Treatment Market Forecast (2021-2026)
Figure Other Regions Sales Substance Use Disorders (SUDs) Treatment Market Forecast (2021-2026)
Table Global Substance Use Disorders (SUDs) Treatment Sales Forecast by Type (2021-2026)
Table Global Substance Use Disorders (SUDs) Treatment Market Share Forecast by Type (2021-2026)
Table Global Substance Use Disorders (SUDs) Treatment Sales Forecast by Application (2021-2026)
Table Global Substance Use Disorders (SUDs) Treatment Market Share Forecast by Application (2021-2026)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Substance Use Disorders (SUDs) Treatment
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Substance Use Disorders (SUDs) Treatment Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Substance Use Disorders (SUDs) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Substance Use Disorders (SUDs) Treatment Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Substance Use Disorders (SUDs) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Substance Use Disorders (SUDs) Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Substance Use Disorders (SUDs) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Substance Use Disorders (SUDs) Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Substance Use Disorders (SUDs) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)